FAQs ABOUT EPAREL 50MG
Can EPAREL 50MG be used in children?
As, safety and effectiveness of EPAREL 50MG have not been established in children and adolescents (under 18 years of age). Consult child’s doctor for advice. Your doctor will decide the correct dose or select a suitable alternative therapy for your child.
Can EPAREL 50MG cause vomiting?
Vomiting is a common side effect associated with the use of EPAREL 50MG. To manage this effect, get adequate rest and drink lot of fluids, especially water. Have small sips if you feel sick. Do not lie down immediately after eating. Do not take any medicine for vomiting without asking your doctor. Tell your doctor if you have continuous vomiting.
What precautions do I need to follow while taking EPAREL 50MG?
Patients taking EPAREL 50MG must inform their doctor about their pre-existing conditions like kidney, liver, or heart problems. Patients should also inform if they are pregnant, breast-feeding, or having any allergies. Consult your doctor if you experience any unusual effects.
Can EPAREL 50MG be used during pregnancy?
EPAREL 50MG should be used with caution during pregnancy only if it is clearly advised by your doctor. If you think you are pregnant, or planning to get pregnant, consult your doctor before taking this medicine. Inform your doctor immediately if you become pregnant during treatment with EPAREL 50MG.
Can I take other medicines with EPAREL 50MG?
Before taking EPAREL 50MG, inform your doctor if you are taking, have taken, or might take any other medicine, including prescription, non-prescription or any herbal medicine, as these might interact with each other and alter the effect of the medicine.
How does EPAREL 50MG work?
EPAREL 50MG works by inhibiting an enzyme (aldose reductase) which converts glucose into sorbitol. In diabetics, there is an excess sorbitol production that gets deposited in nerves and other tissues, causing diabetic neuropathy. By inhibiting the enzyme, epalrestat delays sorbitol accumulation in nerves and other tissues thus delaying the progression and occurrence of diabetic neuropathy in affected individuals.